Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma (original) (raw)

• Sherr, C.J. Mammalian G1 cyclins. cell. 73, 1059–1065 (1993).
  Article CAS PubMed Google Scholar
• Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366, 704–707 (1993).
  Article CAS PubMed Google Scholar
• Serrano, M., Gomez-Lahoz, E., DePinho, R., Beach, D. & Bar-Sagi, D. Inhibition of Ras-induced proliferation and cellular transformation by p16INK4. Science. 267, 249–252 (1995).
  Article CAS PubMed Google Scholar
• Hannon, G.J. & Beach, D. pl5INK4B is a potential effector of TGF-b-induced cell cycle arrest. Nature. 371, 257–261 (1994).
  Article CAS PubMed Google Scholar
• Guan, K-L. et al. Growth suppression of p18, a P16INK4/MTS1 and p14iNK4BMrs2_re|ated CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939–2952 (1994).
  Article CAS PubMed Google Scholar
• Hussussian, C.J. et al. Germline p16 mutations in familial melanoma. Nature Genet. 8, 15–21 (1994).
  Article CAS PubMed Google Scholar
• Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 22–26 (1994).
  Article CAS Google Scholar
• MacGeoch, C. et al. Genetic heterogeneity in familial malignant melanoma Hum. Molec. Genet. 3, 2195–2200 (1994).
  CAS Google Scholar
• Gruis, N.A. et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet. 10, 351–353 (1995).
  Article CAS PubMed Google Scholar
• Ohta, M. et al. Rarity of somatic and germline mutations of the cyclin dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res. 54, 5269–5272 (1994).
  CAS PubMed Google Scholar
• Liu, L. et al. .Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene. 11, 405–412 (1995).
  CAS PubMed Google Scholar
• Walker, G.J. et al. .Mutations of the CDKN2/ p16INK4 gene in Australian melanoma kindreds. Hum. Molec. Genet. 4, 1845–1852 (1995).
  CAS Google Scholar
• Wotfel, T. et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269, 1281–1284 (1995).
  Article Google Scholar
• Mulligan, L.M. et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363, 458–460 (1993).
  Article CAS PubMed Google Scholar
• Donis-Keller, H. et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Molec. Genet. 2, 851–856 (1993).
  CAS Google Scholar
• Hofstra, R.M. et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367, 375–376 (1994).
  Article CAS PubMed Google Scholar
• Goldstein, A.M., Dracopoli, N.C., Engelstein, M., Fraser, M.C., Clark, W.H., & Tucker, M.A. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am. J. Hum. Genet. 54, 489–496 (1994).
  CAS PubMed PubMed Central Google Scholar
• Goldstein, A.M. et al. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1 p and evidence for genetic heterogeneity. Am. J. hum. Genet. 52, 537–550 (1993).
  CAS PubMed PubMed Central Google Scholar
• Ranade, K. et al. Mutations associated with familial melanoma impair p16INK4 function. Nature Genet. 10, 114–116 (1995).
  Article CAS PubMed Google Scholar
• Hanks, S.K. Homology probing: Identification of cDNA clones encoding members of the protein-serine kinase family. Proc. Natl. Acad. Sci. USA. 84, 388–392 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Demetrick, D.J., Zhang, H. & Beach, D.H. Chromosomal mapping of human CDK2, CDK4 and CDK6 cell cycle kinase genes. Cyfogenef. Cell Genet. 66, 72–74 (1994).
  Article CAS Google Scholar
• Fountain, J.W., Bale, S.J., Housman, D.E. & Dracopoli, N.C. Genetics of melanoma. Cancer Surv. 9, 645–671 (1990).
  CAS PubMed Google Scholar
• Nancarrow, D.J. et al. Confirmation of chromosome 9p linkage in familial melanoma. Am. J. Hum. Genet. 53, 936–942 (1993).
  CAS PubMed PubMed Central Google Scholar
• Laird, R.W, Jaenisch, R. DNA methylation and cancer. Hum. Molec. Genet. 3, 1487–1495 (1994).
  Article CAS PubMed Google Scholar
• Otterson, G.A., Kratzke, R.A., Coxon, A., Kirn, Y.W. & Kaye, F.J. Absence of p16iNK4 is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene. 9, 3375–3378 (1994).
  CAS PubMed Google Scholar
• Khatib, Z.A. et al. Coamplification of the CDK4 gene with MDM2 and GLI. in human sarcomas. Cancer Res. 53, 5535–5541 (1993).
  CAS PubMed Google Scholar
• Ladanyi, M. et al. MDM2 and CDK4 gene amplification in Ewing's sarcoma. J. Pathol. 175, 211–217 (1995).
  Article CAS PubMed Google Scholar
• Schmidt, E.E., Ichimura, K., Reifenberger, G. & Collins, V.R. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 54, 6321–6324 (1994).
  CAS PubMed Google Scholar
• He, J. et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res. 54, 5804–5807 (1994).
  CAS PubMed Google Scholar
• Separation Technique File No.131: PCR-SSCP Analysis. Pharmacia Biotech, Alameda, Ca. (1995).